FDA Adverse Event Injury Summary report: N

CONTAK RENEWAL

MDR report key: 3211066 · Received July 8, 2013

Report

Report Number
2124215-2013-07470
Event Type
Injury
Date Received
July 8, 2013
Date of Event
April 19, 2013
Report Date
April 24, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
NIK
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS CURRENTLY AVAILABLE, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE CLINIC FOLLOW-UP VISIT CONDUCTED BY THE PHYSICIAN, THIS PATIENT PREVIOUSLY EXPERIENCED SYNCOPE DUE TO INHIBITION OF PACING. AN ASSOCIATED DEVICE REPORT INDICATED A DIVERTED THERAPY EPISODE, WITH NOISE ON THE RIGHT VENTRICULAR (RV) CHANNEL, AND ASYSTOLE (I.E. FLAT LINE) ON THE SHOCK CHANNEL. VALUES FOR THE PACING AND SHOCK IMPEDANCE MEASUREMENTS WERE WITHIN NORMAL RANGE. NOISE WAS NOT REPRODUCIBLE WHEN APPROPRIATELY TESTED. THE SYSTEM REMAINS IMPLANTED, BUT THE PHYSICIAN WILL PLAN TO REPLACE THE CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) AS IT IS NEARING END OF LIFE. APPROXIMATELY ONE WEEK LATER, THE PHYSICIAN SURGICALLY ABANDONED AND REPLACED THE CHRONIC LEAD AND EXPLANTED THE DEVICE. THE DEVICE WAS DISCARDED AT THE HOSPITAL AND WILL NOT BE RETURNED. NEW PRODUCTS WERE SUCCESSFULLY IMPLANTED; THE DEVICE OF A NON-BOSTON SCIENTIFIC PRODUCT. NO ADDITIONAL ADVERSE EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310933 CONTAK RENEWAL IMPLANTABLE CHF GENERATOR NIK GUIDANT CRM CLONMEL IRELAND H230

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R